233 related articles for article (PubMed ID: 31635026)
1. Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.
Santos I; Ramos C; Mendes C; Sequeira CO; Tomé CS; Fernandes DGH; Mota P; Pires RF; Urso D; Hipólito A; Antunes AMM; Vicente JB; Pereira SA; Bonifácio VDB; Nunes SC; Serpa J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31635026
[TBL] [Abstract][Full Text] [Related]
2. The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy.
Lopes-Coelho F; Martins F; Hipólito A; Mendes C; Sequeira CO; Pires RF; Almeida AM; Bonifácio VDB; Pereira SA; Serpa J
Front Oncol; 2021; 11():656229. PubMed ID: 34041026
[TBL] [Abstract][Full Text] [Related]
3. Cystine/Glutamate Xc
Orlowska K; Fling RR; Nault R; Schilmiller AL; Zacharewski TR
Chem Res Toxicol; 2023 Jun; 36(6):900-915. PubMed ID: 37184393
[TBL] [Abstract][Full Text] [Related]
4. Role of the cystathionine β-synthase/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system.
Jia H; Ye J; You J; Shi X; Kang W; Wang T
Oncol Rep; 2017 May; 37(5):3001-3009. PubMed ID: 28440458
[TBL] [Abstract][Full Text] [Related]
5. Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy.
Martins IL; Charneira C; Gandin V; Ferreira da Silva JL; Justino GC; Telo JP; Vieira AJ; Marzano C; Antunes AM
J Med Chem; 2015 May; 58(10):4250-65. PubMed ID: 25906385
[TBL] [Abstract][Full Text] [Related]
6. Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
Kawahara B; Ramadoss S; Chaudhuri G; Janzen C; Sen S; Mascharak PK
J Inorg Biochem; 2019 Feb; 191():29-39. PubMed ID: 30458366
[TBL] [Abstract][Full Text] [Related]
7. Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance.
Cruz A; Mota P; Ramos C; Pires RF; Mendes C; Silva JP; Nunes SC; Bonifácio VDB; Serpa J
Antioxidants (Basel); 2020 Feb; 9(2):. PubMed ID: 32028640
[No Abstract] [Full Text] [Related]
8. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
9. Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation.
Zhu H; Chan KT; Huang X; Cerra C; Blake S; Trigos AS; Anderson D; Creek DJ; De Souza DP; Wang X; Fu C; Jana M; Sanij E; Pearson RB; Kang J
Elife; 2022 Jun; 11():. PubMed ID: 35758651
[TBL] [Abstract][Full Text] [Related]
10. Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.
Nunes SC; Ramos C; Lopes-Coelho F; Sequeira CO; Silva F; Gouveia-Fernandes S; Rodrigues A; Guimarães A; Silveira M; Abreu S; Santo VE; Brito C; Félix A; Pereira SA; Serpa J
Sci Rep; 2018 Jun; 8(1):9513. PubMed ID: 29934500
[TBL] [Abstract][Full Text] [Related]
11. H
Hipólito A; Mendes C; Martins F; Lemos I; Francisco I; Cunha F; Almodôvar T; Albuquerque C; Gonçalves LG; Bonifácio VDB; Vicente JB; Serpa J
Antioxidants (Basel); 2023 Dec; 13(1):. PubMed ID: 38247476
[TBL] [Abstract][Full Text] [Related]
12. Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
Bhattacharyya S; Saha S; Giri K; Lanza IR; Nair KS; Jennings NB; Rodriguez-Aguayo C; Lopez-Berestein G; Basal E; Weaver AL; Visscher DW; Cliby W; Sood AK; Bhattacharya R; Mukherjee P
PLoS One; 2013; 8(11):e79167. PubMed ID: 24236104
[TBL] [Abstract][Full Text] [Related]
13. HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).
Lopes-Coelho F; Gouveia-Fernandes S; Gonçalves LG; Nunes C; Faustino I; Silva F; Félix A; Pereira SA; Serpa J
Tumour Biol; 2016 Apr; 37(4):4813-29. PubMed ID: 26520442
[TBL] [Abstract][Full Text] [Related]
14. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
15. Biological insights in non-small cell lung cancer.
Rosell R; Jain A; Codony-Servat J; Jantus-Lewintre E; Morrison B; Ginesta JB; González-Cao M
Cancer Biol Med; 2023 Jun; 20(7):500-18. PubMed ID: 37381723
[TBL] [Abstract][Full Text] [Related]
16. Cystathionine β-synthase regulates mitochondrial morphogenesis in ovarian cancer.
Chakraborty PK; Murphy B; Mustafi SB; Dey A; Xiong X; Rao G; Naz S; Zhang M; Yang D; Dhanasekaran DN; Bhattacharya R; Mukherjee P
FASEB J; 2018 Aug; 32(8):4145-4157. PubMed ID: 29494264
[TBL] [Abstract][Full Text] [Related]
17. Role of cystathionine β-synthase in human breast Cancer.
Sen S; Kawahara B; Gupta D; Tsai R; Khachatryan M; Roy-Chowdhuri S; Bose S; Yoon A; Faull K; Farias-Eisner R; Chaudhuri G
Free Radic Biol Med; 2015 Sep; 86():228-38. PubMed ID: 26051168
[TBL] [Abstract][Full Text] [Related]
18. S-glutathionylation enhances human cystathionine β-synthase activity under oxidative stress conditions.
Niu WN; Yadav PK; Adamec J; Banerjee R
Antioxid Redox Signal; 2015 Feb; 22(5):350-61. PubMed ID: 24893130
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of cystathionine β-synthetase/hydrogen sulfide inhibition in cancer.
Hellmich MR; Coletta C; Chao C; Szabo C
Antioxid Redox Signal; 2015 Feb; 22(5):424-48. PubMed ID: 24730679
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II).
Zuhra K; Panagaki T; Randi EB; Augsburger F; Blondel M; Friocourt G; Herault Y; Szabo C
Biochem Pharmacol; 2020 Dec; 182():114267. PubMed ID: 33035509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
